Choice of Topotecan or Melphalan in Retinoblastoma Patients
Who is this study for? Patients with Retinoblastoma
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 3
SUMMARY
The purpose of this study is to evaluate topotecan and melphalan for retinoblastoma patients.
Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:
• diagnosed as retinoblastoma
• receiving eyeball-sparing treatment
Locations
Other Locations
China
Sun Yat-sen University
RECRUITING
Guangzhou
Contact Information
Primary
Huasheng Yang
yanghs64@126.com
+00862087331539
Backup
Huijing Ye
yehuijing@qq.com
+00862087331539
Time Frame
Start Date: 2021-03-11
Estimated Completion Date: 2027-12-30
Participants
Target number of participants: 50
Treatments
Active_comparator: Topotecan
Topotecan intraocular injection during chemotherapy
Experimental: Melphalan
Melphalan intraocular injection during chemotherapy
Related Therapeutic Areas
Sponsors
Leads: Sun Yat-sen University